Kymera Therapeutics KYMR

3 headline mentions across 300+ news sites in the last 30 days.

Headline mentions3last 30 days

Average tone +0.00 0 positive, 0 negative

Daily news coverage

Bars show how many headlines mentioned Kymera Therapeutics on each day we took a news snapshot; the line shows their average tone.

+0.00
STAT Plus:Coming readout of Kymera eczema trial is a high-stakes moment in a bid to rival Dupixent
statnews.com · Nov 03

10-Q
Quarterly report 2026-10-29
8-K
Current report 2026-10-29
SCHEDULE 13G/A
Passive stake (5%+) 2026-10-27
SCHEDULE 13G/A
Passive stake (5%+) 2026-09-08
SCHEDULE 13G/A
Passive stake (5%+) 2026-08-14
SCHEDULE 13G/A
Passive stake (5%+) 2026-08-13
10-Q
Quarterly report 2026-08-05
8-K
Current report 2026-08-05
8-K
Current report 2026-07-27 · 8-K Item 5.02: Director or officer change
SCHEDULE 13D/A
Activist stake (5%+) 2026-06-26 · SCHEDULE 13D/A: Activist stake (5%+)
8-K
Current report 2026-06-25
8-K
Current report 2026-06-24

Plus 5 insider trading forms (Forms 3, 4, 5 and 144) in the last 90 days, not listed here.

Watch Kymera Therapeutics

Pulse Index alerts you when Kymera Therapeutics files with the SEC, or is mentioned on the YouTube channels, news feeds and websites you follow.

See Premium Most mentioned companies